Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-10-058934)

Filing Details

Accession Number:: 0001104659-10-058934
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-17 16:13:05
Reporting Period:: 2010-11-15

Filing Date:: 2010-11-17
Accepted Time:: 2010-11-17 16:13:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142380	Callisto Pharmaceuticals Inc	CLSP	Pharmaceutical Preparations (2834)	651107840

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253803	Gabriel Cerrone	C/O Callisto Pharmaceuticals, Inc. 420 Lexington Avenue, Suite 1609 New York NY 10170		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-15	12,935	$0.00	3,492,727	No	4	P	Indirect	By Panetta Partners, Ltd.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Panetta Partners, Ltd.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Purchase Warrants	Disposition	2010-11-15	30,000	$0.00	30,000	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2006-10-23	2011-10-23	No	4	C	Indirect

Footnotes

Shares were acquired through the exercise of Common Stock Purchase Warrants on a cashless basis.
Mr. Cerrone is the sole managing partner of Panetta Partners, Ltd. and in such capacity only exercises voting and dispositive control over securities owned by Panetta, despite him having only a small pecuniary interest in such securities.